These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17239053)

  • 21. Comments on "Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder".
    Pae CU; Han C; Marks DM; Patkar AA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):595-6. PubMed ID: 18061327
    [No Abstract]   [Full Text] [Related]  

  • 22. Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities.
    Hellings JA
    J Clin Psychopharmacol; 2006 Jun; 26(3):344-6. PubMed ID: 16702908
    [No Abstract]   [Full Text] [Related]  

  • 23. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder.
    Hamer RM; Simpson PM
    Biol Psychiatry; 1999 Dec; 46(12):1711-2. PubMed ID: 10624556
    [No Abstract]   [Full Text] [Related]  

  • 24. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder.
    Bowden CL; Calabrese JR; McElroy SL; Rhodes LJ; Keck PE; Cookson J; Anderson J; Bolden-Watson C; Ascher J; Monaghan E; Zhou J
    Biol Psychiatry; 1999 Apr; 45(8):953-8. PubMed ID: 10386176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential risks associated with high-dose valproate in pregnancy in psychiatric patients.
    Vajda FJ; Solinas C
    Aust N Z J Psychiatry; 2005 Jun; 39(6):526-7. PubMed ID: 15943661
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjunctive lamotrigine as a possible mania inducer in bipolar patients.
    Raskin S; Teitelbaum A; Zislin J; Durst R
    Am J Psychiatry; 2006 Jan; 163(1):159-60. PubMed ID: 16390907
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Valproate in the treatment of bipolar disorder].
    Rzewuska M
    Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divalproex for the treatment of aggression associated with adolescent mania.
    DelBello MP; Adler C; Strakowski SM
    J Child Adolesc Psychopharmacol; 2004; 14(2):325-8. PubMed ID: 15319029
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review.
    Sharma V; Khan M; Corpse C
    J Affect Disord; 2008 Nov; 111(1):100-5. PubMed ID: 18314200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
    Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
    Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
    Bourin M; Prica C
    Neurosci Biobehav Rev; 2007; 31(6):963-75. PubMed ID: 17462734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy of levosulpiride and lamotrigine associated with tardive dyskinesia.
    Mendhekar DN; Gupta N
    Aust N Z J Psychiatry; 2009 Feb; 43(2):178-9. PubMed ID: 19165957
    [No Abstract]   [Full Text] [Related]  

  • 35. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L; Llorca PM
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
    Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
    Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.
    Bramness JG; Grøholt B; Engeland A; Furu K
    J Affect Disord; 2009 Oct; 117(3):208-11. PubMed ID: 19189871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bipolar rapid cycling: focus on depression as its hallmark.
    Calabrese JR; Shelton MD; Bowden CL; Rapport DJ; Suppes T; Shirley ER; Kimmel SE; Caban SJ
    J Clin Psychiatry; 2001; 62 Suppl 14():34-41. PubMed ID: 11469674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
    Singh V; Bowden CL; Mintz J
    Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Creech RS; Welge JA; Jefferson L; Guerdjikova AI; Keck PE
    J Clin Psychiatry; 2010 May; 71(5):557-65. PubMed ID: 20361901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.